-
1 Comment
Beijing Tongrentang Co., Ltd is currently in a long term uptrend where the price is trading 27.9% above its 200 day moving average.
From a valuation standpoint, the stock is 67.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.1.
Beijing Tongrentang Co., Ltd's total revenue rose by 13.7% to $4B since the same quarter in the previous year.
Its net income has increased by 133.8% to $316M since the same quarter in the previous year.
Finally, its free cash flow fell by 122.7% to $-70M since the same quarter in the previous year.
Based on the above factors, Beijing Tongrentang Co., Ltd gets an overall score of 4/5.
| Exchange | SHG |
|---|---|
| ISIN | CNE000000R69 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| CurrencyCode | CNY |
| Beta | 0.24 |
|---|---|
| Market Cap | 50B |
| PE Ratio | 32.68 |
| Target Price | 48.77 |
| Dividend Yield | None |
Beijing Tongrentang Co., Ltd engages in the scientific research, production, distribution, and sale of Chinese medicines in China. The company provides product dosage forms, such as pills, powders, wine preparations, capsules, and oral liquids in the areas of cardiovascular, gynecology, heat clearing class, respiratory system, nourishing and calming, digestive system, pediatrics, wind-dispelling and dampness-removing, orthopedics, five senses, dermatology, psychological, and food and wine. The company was founded in 1997 and is headquartered in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tongrentang (Group) Co., Ltd.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600085.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
